Relationship between MIC and minimum sterol 14α-demethylation- inhibitory concentration as a factor in evaluating activities of azoles against various fungal species

Journal of Clinical Microbiology

Volumn 43, Issue 11, 2005, Pages 5547-5549

  Shimokawa, Osamu ^a,d   Niimi, Masakazu ^c   Kikuchi, Ken ^c   Saito, Mitsumasa ^b   Kajiwara, Hideko ^b   Yoshida, Shin Ichi ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE; STEROL;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONCENTRATION (PARAMETERS); CRYPTOCOCCUS; CRYPTOCOCCUS CURVATUS; CRYPTOCOCCUS NEOFORMANS; DEMETHYLATION; MINIMUM INHIBITORY CONCENTRATION; MINIMUM STEROL 14ALPHA DEMETHYLATION INHIBITOR CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPOROTHRIX SCHENCKII; STEROL METABOLISM; TRICHOSPORON ASAHII;

ACETATES; ASPERGILLUS FUMIGATUS; AZOLES; CANDIDA; CHROMATOGRAPHY, THIN LAYER; CULTURE MEDIA; FUNGI; HUMANS; LANOSTEROL; MICROBIAL SENSITIVITY TESTS; MITOSPORIC FUNGI; MYCOSES; SPECIES SPECIFICITY; STEROLS;

ASPERGILLUS FUMIGATUS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; CRYPTOCOCCUS CURVATUS; FILOBASIDIELLA NEOFORMANS; FUNGI; ISSATCHENKIA ORIENTALIS; PICHIA GUILLIERMONDII; SPOROTHRIX SCHENCKII; TRICHOSPORON ASAHII;

EID: 27744446256     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.11.5547-5549.2005     Document Type: Article

References (21)

1. al-Rawi, N., and K. Kavanagh. 1999. Characterization of yeasts implicated in vulvovaginal candidosis in Irish women. Br. J. Biomed. Sci. 56:99-104.
2. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
3. De Brabander, M., F. Aerts, J. Van Custem, H. Vanden Bossche, and M. Borgers. 1980. The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans. Sabouraudia 18:197-210.
4. Garcha, U. K., E. Brummer, and D. A. Stevens. 1995. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species. J. Infect. Dis. 172:1620-1623.
5. Hazen, K. C., G. Mandell, E. Coleman, and G. Wu. 2000. Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis of Candida albicans. FEMS Microbiol. Lett. 183:89-94.
6. Kurtzman, C. P., and C. J. Robnett. 1997. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J. Clin. Microbiol. 35:1216-1223.
7. Minguez, F., J. E. Lima, M. T. Garcia, and J. Prieto. 1997. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes. Chemotherapy 43:346-351.
8. Mouligner, D. F., B. Dupont, E. Gueho, M. Baudrimont, L. Imprevisi, F. Provost, and G. Gonzalez-Canali. 1995. Myeloradiculitis due to Cryptococcus curvatus in AIDS. AIDS 9:395-396.
9. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth microdilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Rodriguez-Del Valle, N., M. Rosario, and G. Torres-Blasini. 1983. Effects of pH, temperature, aeration and carbon source on the development of the mycelial or yeast forms of Sporothrix schenckii from conidia. Mycopathologia 82:83-88.
11. Shigematsu, M. L., J. Uno, and T. Arai. 1981. Correlative studies on in vivo and in vitro effectiveness of ketoconazole (R41400) against Candida albicans infection. Jpn. J. Med. Mycol. 22:195-201.
12. Shimokawa, O., Y. Kato, and H. Nakayama. 1986. Accumulation of 14-methyl sterols and defective hyphal growth in Candida albicans, J. Med. Vet. Mycol. 24:327-336.
13. Shimokawa, O., Y. Kato, and H. Nakayama. 1986. Increased drug sensitivity in Candida albicans cells accumulating 14-methylated sterols. J. Med. Vet. Mycol. 24:481-483.
14. Shimokawa, O., Y. Kato, K. Kawano, and H. Nakayama. 1989. Accumulation of 14α-methylergosta-8,24(28)-dien-3β,6α-diol in 14α-demethylation mutants of Candida albicans: genetic evidence for the involvement of 5-desaturase. Biochim. Biophys. Acta 1003:15-19.
15. Shimokawa, O., and H. Nakayama. 1989. A Candida albicans mutant conditionally defective in sterol 14α-demethylation. J. Med. Vet. Mycol. 27:121-125.
16. Shimokawa, O., and H. Nakayama. 1992. Increased sensitivity of Candida albicans cells accumulating 14α-methylated sterols to active oxygen: possible relevance to in vivo efficacies of azole antifungal agents. Antimicrob. Agents Chemother. 36:1626-1629.
17. Shimokawa, O., and H. Nakayama. 1999. Acetate-mediated growth inhibition in sterol 14α-demethylation-deficient cells of Candida albicans. Antimicrob. Agents Chemother. 43:100-105.
18. Shimokawa, O., and H. Nakayama. 2000. Estimation of minimum sterol 14α-demethylation-inhibitory concentration of azoles in Candida yeasts using acetate-mediated growth inhibition: potential utility in susceptibility testing. J. Clin. Microbiol. 38:2893-2896.
19. Tokimatsu, I., R. Karashima, E. Yamagata, Y. Yamakami, H. Nagai, J. Kadota, and M. Nasu. 2003. Pathogenesis of Trichosporon asahii and strategies for infectious control of disseminated trichosporonosis. Jpn. J. Med. Mycol. 44:181-186.
20. Tullio, V., A. M. Cuffini, C. De Leo, F. Perrone, and N. A. Carlone. 1996. Interaction of Candida albicans, macrophages and fluconazole: in vitro and ex vivo observations. J. Chemother. 8:438-444.
21. Vanden Bossche, H., G. Willemsens, W. Cools, W. F. G. Lauwers, and L. Le Jeune. 1978. Biochemical effects of miconazole on fungi II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem.-Biol. Interact. 21:59-78.